Lilly’s Jaypirca (pirtobrutinib) Shows Significant Progression-Free Survival Benefit in Treatment-Naïve CLL/SLL Read more
Lilly’s Olomorasib Gets FDA Breakthrough Therapy Nod for New Metastatic KRAS G12C Lung Cancer Treatment Read more
Argo Biopharma Secures Multi-Asset License and Option Deals with Novartis for Cardiovascular Drug Candidates Read more
Gilead Partners with PEPFAR to Provide Twice-Yearly HIV Prevention to 2 Million People in Low-Income Countries Read more
Amgen to Invest Over $600 Million in New Science and Innovation Center at U.S. Headquarters Read more